1. Outbreak of hypoglycaemia: sexual enhancement products containing oral hypoglycaemic agent.
- Author
-
Poon WT, Lam YH, Lee HH, Ching CK, Chan WT, Chan SS, Lai CK, Tse ML, Chan AY, and Mak TW
- Subjects
- Administration, Oral, Adult, Aged, Aged, 80 and over, Drug Combinations, Glyburide administration & dosage, Hong Kong, Humans, Hypoglycemia chemically induced, Hypoglycemic Agents administration & dosage, Male, Middle Aged, Piperazines administration & dosage, Purines administration & dosage, Purines adverse effects, Retrospective Studies, Sildenafil Citrate, Sulfones administration & dosage, Vasodilator Agents administration & dosage, Disease Outbreaks statistics & numerical data, Glyburide adverse effects, Hypoglycemia epidemiology, Hypoglycemic Agents adverse effects, Piperazines adverse effects, Sexual Behavior, Sulfones adverse effects, Vasodilator Agents adverse effects
- Abstract
Objectives: To describe a cluster of Hong Kong subjects with hypoglycaemia, after they had taken various non-prescription sildenafil products containing glibenclamide., Design: Retrospective study., Setting: A tertiary referral centre for clinical toxicology analysis in Hong Kong., Patients: All men referred to the laboratory for investigation of suspected drug-induced hypoglycaemia from December 2007 to September 2008., Main Outcome Measures: The characteristics of these patients, including their clinical presentations, outcomes, drug history, urine toxicology analysis results, and in some instances, analysis results of unused products., Results: A total of 144 male patients were referred for suspected drug-induced hypoglycaemia. Sildenafil and glibenclamide, or their metabolites, were detected in the urine specimens of 68 (47%) patients, none of whom had been prescribed either drug by a registered medical practitioner. Among these subjects, 24 (35%) denied any use of sexual enhancement products despite repeated questioning. Eight patients had repeated exposure resulting in re-admission. The sources of these sexual enhancement products included pharmacies in Mainland China, friends, local pharmacies, peddlers, or were unknown. Three patients died, one remains in a vegetative state and one suffered cognitive impairment; the remaining 63 recovered fully. Twenty-five unused sexual enhancement products of seven different kinds were recovered for analysis. The median (range) of sildenafil and glibenclamide per unit dose was 64 (0.05-198) mg and 70 (0-158) mg, respectively., Conclusion: These illegal products pose a severe and continued threat to society and therefore deserve widespread vigilance, so that such products can be eradicated at their source.
- Published
- 2009